Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration
- PMID: 29404727
- DOI: 10.1007/s00441-018-2792-3
Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration
Abstract
Satellite cell-mediated skeletal muscle repair/regeneration is compromised in cases of extended damage. Bone marrow mesenchymal stromal cells (BM-MSCs) hold promise for muscle healing but some criticisms hamper their clinical application, including the need to avoid animal serum contamination for expansion and the scarce survival after transplant. In this context, platelet-rich plasma (PRP) could offer advantages. Here, we compare the effects of PRP or standard culture media on C2C12 myoblast, satellite cell and BM-MSC viability, survival, proliferation and myogenic differentiation and evaluate PRP/BM-MSC combination effects in promoting myogenic differentiation. PRP induced an increase of mitochondrial activity and Ki67 expression comparable or even greater than that elicited by standard media and promoted AKT signaling activation in myoblasts and BM-MSCs and Notch-1 pathway activation in BM-MSCs. It stimulated MyoD, myogenin, α-sarcomeric actin and MMP-2 expression in myoblasts and satellite cell activation. Notably, PRP/BM-MSC combination was more effective than PRP alone. We found that BM-MSCs influenced myoblast responses through a paracrine activation of AKT signaling, contributing to shed light on BM-MSC action mechanisms. Our results suggest that PRP represents a good serum substitute for BM-MSC manipulation in vitro and could be beneficial towards transplanted cells in vivo. Moreover, it might influence muscle resident progenitors' fate, thus favoring the endogenous repair/regeneration mechanisms. Finally, within the limitations of an in vitro experimentation, this study provides an experimental background for considering the PRP/BM-MSC combination as a potential therapeutic tool for skeletal muscle damage, combining the beneficial effects of BM-MSCs and PRP on muscle tissue, while potentiating BM-MSC functionality.
Keywords: AKT signaling; Bone marrow-derived mesenchymal stromal cells (BM-MSCs); Paracrine factors; Platelet-rich plasma (PRP); Skeletal muscle regeneration.
Similar articles
-
The factors present in regenerating muscles impact bone marrow-derived mesenchymal stromal/stem cell fusion with myoblasts.Stem Cell Res Ther. 2019 Nov 21;10(1):343. doi: 10.1186/s13287-019-1444-1. Stem Cell Res Ther. 2019. PMID: 31753006 Free PMC article.
-
The Effects of Platelet-Rich and Platelet-Poor Plasma on Biological Characteristics of BM-MSCs In Vitro.Anal Cell Pathol (Amst). 2020 Aug 26;2020:8546231. doi: 10.1155/2020/8546231. eCollection 2020. Anal Cell Pathol (Amst). 2020. PMID: 32908815 Free PMC article.
-
Effect of Platelet-Rich Plasma on Chondrogenic Differentiation of Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells.Tissue Eng Part A. 2018 Oct;24(19-20):1432-1443. doi: 10.1089/ten.tea.2018.0065. Epub 2018 Jul 23. Tissue Eng Part A. 2018. PMID: 30036140
-
Influence of Platelet-Rich and Platelet-Poor Plasma on Endogenous Mechanisms of Skeletal Muscle Repair/Regeneration.Int J Mol Sci. 2019 Feb 5;20(3):683. doi: 10.3390/ijms20030683. Int J Mol Sci. 2019. PMID: 30764506 Free PMC article. Review.
-
The application of bone marrow mesenchymal stem cells and biomaterials in skeletal muscle regeneration.Regen Ther. 2020 Nov 28;15:285-294. doi: 10.1016/j.reth.2020.11.002. eCollection 2020 Dec. Regen Ther. 2020. PMID: 33426231 Free PMC article. Review.
Cited by
-
Platelet-Rich Plasma Prevents In Vitro Transforming Growth Factor-β1-Induced Fibroblast to Myofibroblast Transition: Involvement of Vascular Endothelial Growth Factor (VEGF)-A/VEGF Receptor-1-Mediated Signaling †.Cells. 2018 Sep 19;7(9):142. doi: 10.3390/cells7090142. Cells. 2018. PMID: 30235859 Free PMC article.
-
Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020.Int J Mol Sci. 2020 Oct 21;21(20):7794. doi: 10.3390/ijms21207794. Int J Mol Sci. 2020. PMID: 33096812 Free PMC article. Review.
-
Bone Marrow-Mesenchymal Stromal Cell Secretome as Conditioned Medium Relieves Experimental Skeletal Muscle Damage Induced by Ex Vivo Eccentric Contraction.Int J Mol Sci. 2021 Mar 31;22(7):3645. doi: 10.3390/ijms22073645. Int J Mol Sci. 2021. PMID: 33807453 Free PMC article.
-
The Platelet Concentrates Therapy: From the Biased Past to the Anticipated Future.Bioengineering (Basel). 2020 Jul 30;7(3):82. doi: 10.3390/bioengineering7030082. Bioengineering (Basel). 2020. PMID: 32751638 Free PMC article. Review.
-
Platelet-Derived Mitochondria Attenuate 5-FU-Induced Injury to Bone-Associated Mesenchymal Stem Cells.Stem Cells Int. 2023 Jan 30;2023:7482546. doi: 10.1155/2023/7482546. eCollection 2023. Stem Cells Int. 2023. PMID: 36756493 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous